Introduction
For a long time, immune complexes (ICs) assembly was thought to represent a common 48 pathogenic pathway for several diseases (infections, vasculitis, and connective tissue 49 autoimmune disorders). Actually, concentrations of circulating ICs (CICs) in sera from 50 patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), or systemic 51 scleroderma (SSc) were significantly higher than those in sera from healthy controls [1, 2] . 52 Many researchers have investigated the mechanisms by which ICs could underlie 53 pathogenicity [3] . An autoimmune response is directed against several autoantigens [4, 5] ; 54 therefore, comprehensive profiling of the autoantigens that actually assemble into ICs may 55 provide insight into the pathophysiology of specific autoimmune diseases, and such profiling 56 could form the basis for novel diagnosis and treatment strategies for these diseases. 57 However, such comprehensive profiling studies for CICs are limited because tools screening 58 of ICs are lacking. 59 We developed a proteomic strategy, designated immune complexome analysis, in which 60 ICs are separated from whole serum and then subjected to direct tryptic digestion and 61 nano-liquid chromatography-tandem mass spectrometry (nano-LC-MS/MS) to 62 comprehensively identify and profile constituent antigens in CICs [6] . We used this method 63 to identify CIC-associated antigens in sera from patients with RA, and found that 64 thrombospondin-1 is a constituent of CICs and is more highly specific and sensitive for 65 established and early RA than other conventional diagnostic markers such as rheumatoid 66 4 factor or anti-citrulline-containing protein/peptide antibody [6, 7] . 67 In this report, we used immune complexome analysis of serum to study seven major 68 autoimmune diseases-anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV), 69 Takayasu's arteritis (TA), mixed connective tissue disease (MCTD), dermatomyositis (DM), 70 Sjögren's syndrome (SS), SSc, and SLE-to comprehensively identify antigens incorporated 71 into CICs and find disease-specific antigens. Results and discussion 94 Here, we present the first comprehensive identification of the constituent antigens 95 assembled into CICs from patients with AAV, TA, MCTD, DM, SS, SSc, or SLE (Table S1 ). 96 We identified 341 and 264 human antigens via immune complexome analysis with Protein G 97 or Protein A beads, respectively; 468 distinct antigens were identified in all, and each of these 98 was found in independent samples from two or more patients (Table S2) 
